Harald Reinhart - Apr 3, 2023 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Role
President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
Stock symbol
ZLAB
Transactions as of
Apr 3, 2023
Transactions value $
$0
Form type
4
Date filed
4/5/2023, 04:05 PM
Previous filing
Apr 3, 2023
Next filing
Jun 26, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Award $0 +110K $0.00 110K Apr 3, 2023 American Depositary Shares 110K $33.95 Direct F1, F2, F3
transaction ZLAB Restricted Share Units Award $0 +21.1K $0.00 21.1K Apr 3, 2023 American Depositary Shares 21.1K Direct F3, F4, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options are exercisable for American Depositary Shares (ADSs). The number of securities underlying each option and the exercise price therefor are represented in ADSs. Each ADS represents ten Ordinary Shares of the issuer.
F2 The Stock Options vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant.
F3 Each ADS represents ten Ordinary Shares of the issuer.
F4 Each Restricted Share Unit represents a contingent right to receive one American Depositary Share (ADS), which represents ten Ordinary Shares of the issuer.
F5 The Restricted Share Units vest in equal annual installments over four years beginning on 04/03/2024, the first anniversary of the date of grant. Vested shares will be delivered to the reporting person following vesting.

Remarks:

President and Head of Global Development for Neuroscience, Autoimmune and Infectious Diseases